Szymon Bojanowski

Szymon Bojanowski

Auto-generated profile, based on publicly available information

Szymon Bojanowski

Medical University of Lublin, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MIMagdalena Maria Iwaszko
Magdalena Maria Iwaszko
MSMarcelina Skajewska
Marcelina Skajewska
WZWojciech ZięBka
Wojciech ZięBka
SBSzymon Bojanowski
Szymon Bojanowski
AWAleksandra Wojtera
Aleksandra Wojtera
Introduction: Vitamin D has immunomodulatory effects, which may be relevant in autoimmune and immune-mediated diseases. Aim: The aim of this study was to present current data on the role of vitamin D deficiency in the pathogenesis and course of selected diseases. Methods: A narrative literature review was conducted, including mainly publications from 2018–2026 concerning multiple sclerosis, rheumatoid arthritis, autoimmune thyroid diseases, and inflammatory bowel diseases. Results: Vitamin D deficiency is frequently observed in the analyzed diseases. Mechanistic data indicate its influence on dendritic cells, T and B lymphocytes, and the regulation of the inflammatory response. However, the results of supplementation studies remain heterogeneous; some studies have shown improvement in selected laboratory or radiological parameters or disease activity indices. Conclusions: Available data do not allow vitamin D deficiency to be unequivocally considered a causal factor, nor supplementation to be regarded as a specific immunomodulatory treatment. Correction of confirmed deficiency remains justified, while the effect of supplementation on the long-term course of these diseases requires further research.

23 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMarcelina Skajewska
Marcelina Skajewska
MIMagdalena Iwaszko
Magdalena Iwaszko
ODOliwia DziewięCka
Oliwia DziewięCka
SBSzymon Bojanowski
Szymon Bojanowski
AWAleksandra Wojtera
Aleksandra Wojtera
MLMaciej Lazarek
Maciej Lazarek
Introduction: Adequate hydration is essential for maintaining the body's water balance and overall homeostasis. The relationship between hydration status, fluid intake, and sleep duration and quality remains relatively poorly understood and under-researched. Both insufficient hydration and excessive fluid intake immediately before bedtime may affect the quality of nighttime rest. Objective: The aim of this paper was to summarize current evidence on the relationship between hydration status, the timing of fluid intake, and selected sleep parameters in adults. Materials and methods: A narrative review of the literature available in PubMed was conducted. Publications concerning hydration, dehydration, water and other fluid intake, sleep quality and duration, sleep efficiency, and nocturia were analyzed. Particular attention was given to recent observational and interventional studies, systematic reviews, and meta-analyses published in English. Results: Observational studies provide evidence of associations between hydration status and sleep duration, subjective sleep quality, sleep-onset latency, and sleep efficiency. Findings from experimental studies are less consistent. In some studies, mild dehydration did not significantly affect objective sleep parameters, whereas in others it was associated with greater difficulty falling asleep. Fluid intake before bedtime may increase the risk of nocturia, awakenings, and sleep fragmentation. These relationships were influenced by factors such as age, physical activity, ambient temperature, caffeine, alcohol, chronic diseases, and medications. Conclusions: Hydration status and the timing of fluid intake may affect sleep, but the available evidence does not permit a clear causal relationship to be established. Distributing fluid intake evenly throughout the day and avoiding large volumes immediately before bedtime may have a beneficial effect.

24 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AWAleksandra Wojtera
Aleksandra Wojtera
SBSzymon Bojanowski
Szymon Bojanowski
MSMarcelina Skajewska
Marcelina Skajewska
MIMagdalena Iwaszko
Magdalena Iwaszko
WZWojciech ZięBka
Wojciech ZięBka
NUNina Urantówka
Nina Urantówka
Background. Matcha and coffee are widely consumed sources of caffeine and other bioactive compounds. Caffeine-mediated effects are well established, but the distinct phytochemical profiles of these beverages contribute to different physiological responses. Direct comparisons between matcha and coffee remain limited. Aim. We aim to compare the effects of matcha and coffee on cognitive performance, stress response, and cardiometabolic health, with emphasis on their practical relevance for physically active individuals and their potential applications before, during, and after exercise. Material and methods. This narrative review analyzed recent publications identified through manual searches in PubMed, Scopus, and Google Scholar. Results. Both beverages provide caffeine and may improve alertness, attention, and exercise performance, with coffee currently supported by larger evidence base for acute ergogenic effects. Matcha produce a more balanced state of alertness and may be advantageous for sustained attention under conditions of psychological and subjective arousal. Matcha-derived catechins may influence blood pressure, glucose metabolism, lipid metabolism, inflammation, and oxidative stress. Coffee consumption has been associated with favorable or neutral long-term cardiometabolic outcomes. Conclusions. Matcha and coffee should not be viewed as competing beverages, but sources of distinct combinations of bioactive compounds with potentially complementary functional profiles. Coffee has the strongest evidence for rapid caffeine-mediated stimulation and acute exercise performance, whereas matcha is relevant to sustained cognitive engagement and regular exposure to tea-derived polyphenols.

27 May 2026 in Quality in Sport
Verified
Journal Article
Open access
JBJakub Buziak
Jakub Buziak
JPJulita Papińska
Julita Papińska
SBSzymon Bojanowski
Szymon Bojanowski
MŚMałgorzata Świderska
Małgorzata Świderska
SŚSzymon Świstak
Szymon Świstak
JPJulia Pielacha
Julia Pielacha
Background: Pediatric obstructive sleep apnea (OSA) is a common sleep-related breathing disorder causing recurrent upper airway obstruction during sleep and multiple neurocognitive, behavioral, and cardiovascular complications in children. Aim: This review summarizes current evidence regarding the diagnosis and management of pediatric obstructive sleep apnea. Material and methods: A narrative literature review with PRISMA-informed methodology was conducted using PubMed, Scopus, Web of Science, and Google Scholar databases. Literature published between 2016 and 2026 concerning pediatric OSA, polysomnography, adenotonsillectomy, CPAP therapy, and multidisciplinary treatment was analyzed. Results: Pediatric OSA is associated mainly with adenotonsillar hypertrophy, obesity, craniofacial abnormalities, allergic rhinitis, and neuromuscular disorders. Common manifestations include snoring, witnessed apneas, restless sleep, impaired concentration, hyperactivity, and daytime sleepiness. Polysomnography remains the diagnostic gold standard. Adenotonsillectomy is the first-line treatment, while additional therapies include CPAP, anti-inflammatory treatment, orthodontic interventions, weight reduction, and myofunctional therapy. Persistent OSA after surgery remains common in obese and syndromic patients. Conclusions: Pediatric OSA requires early diagnosis and individualized multidisciplinary management. Appropriate treatment may reduce long-term complications and improve quality of life in affected children.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JBJakub Buziak
Jakub Buziak
JPJulita Papińska
Julita Papińska
SBSzymon Bojanowski
Szymon Bojanowski
KCKatarzyna Cencelewicz
Katarzyna Cencelewicz
PBPatrycja Bździuch
Patrycja Bździuch
MLMagdalena Lengier
Magdalena Lengier
Background: Muscle Tension Dysphonia (MTD) is a common functional voice disorder characterized by excessive laryngeal and paralaryngeal muscle activity during phonation. The disorder negatively affects vocal quality, communication, occupational functioning, and quality of life. Aim: This narrative review summarizes current evidence regarding the pathophysiology, epidemiology, diagnosis, and treatment of Muscle Tension Dysphonia. Material and methods: A PRISMA-informed narrative literature review was conducted using PubMed, Scopus, and Web of Science databases. Publications from 2003–2025 concerning functional dysphonia, laryngeal muscle tension, diagnostic methods, psychosocial factors, and voice therapy were analyzed. Results: Current evidence indicates that MTD is a multifactorial disorder associated with excessive laryngeal tension, maladaptive vocal behaviors, occupational voice overuse, stress, and impaired respiratory-phonatory coordination. Diagnostic assessment should include perceptual voice evaluation, videolaryngostroboscopy, acoustic analysis, and patient-reported outcome measures. Behavioral voice therapy remains the primary evidence-based treatment. Manual circumlaryngeal therapy, semi-occluded vocal tract exercises, respiratory retraining, and psychosocial interventions may additionally improve clinical outcomes. Conclusions: MTD is a complex biopsychosocial disorder requiring individualized and interdisciplinary management. Further high-quality studies are necessary to standardize diagnostic criteria and optimize therapeutic protocols.